Guidance

Cervical screening: pathway for acceptance of new HPV tests

This guidance outlines the process for accepting new human papillomavirus (HPV) tests for use in UK cervical screening programmes.

From:
NHS England
Published
5 July 2019
Last updated
26 September 2024 — See all updates

Documents

Cervical screening: pathway for acceptance of new human papillomavirus tests

Ref: PHE publications gateway number: GW-501

HTML

Appendix A: application process for commercial providers

Ref: PHE publications gateway number: GW-501

HTML

Appendix B: new technology supplier checklist

Ref: PHE publications gateway number: GW-501

HTML

Details

This document sets out:

  • the pathway for accepting new human papillomavirus tests for cervical screening
  • the application process for commercial providers (Appendix A)
  • a checklist for commercial providers submitting information to support their application (Appendix B)

This publication was originally published by Public Health England, which closed on 30 September 2021.

Updates to this page

Published 5 July 2019
Last updated 26 September 2024 + show all updates

  1. Added clarification that publication was originally published by Public Health England.

  2. Added the 7. Verification of a new pre-analytic system in the 'Cervical screening: pathway for acceptance of new human papillomavirus tests' document

  3. Added acceptance criteria and elaborated on stress test and validation report in section 3 in pathways and minor corrections in appendix A and B.

  4. First published.

Sign up for emails or print this page

Related content